Executive Employment Agreement btwn Trimeris and James R. Thomas



 Exhibit 10.1 
 EXECUTION COPY 
 EXECUTIVE EMPLOYMENT AGREEMENT 

THIS AGREEMENT is made and entered into this the 18th day of November, 2010, by and between TRIMERIS, INC., a Delaware corporation (the
“Company”), and JAMES R. THOMAS (“Executive”). 
 W I T N E S S E T
H: 
 WHEREAS, Executive and the Company deem it to be in their respective best interests to enter into an agreement providing
for the Company’s employment of Executive pursuant to the terms herein stated; 
 NOW, THEREFORE, in consideration of the premises
and the mutual promises and agreements contained herein, it is hereby agreed as follows: 
 1. Effective Date. Executive’s
employment under this Agreement shall be effective as of the 18th day of November, 2010 (the “Effective Date”). 
 2.
Position and Duties. 
 (a) Executive shall serve as Chief Financial Officer and Secretary beginning as of the Effective
Date and shall continue in such position until his employment ends as provided under this Agreement. In this capacity, Executive shall devote his full business time, efforts and attention to the performance of his duties, subject to (b) below.
Executive shall have the duties, responsibilities and authority customarily incident to such offices and positions and to such other services commensurate with such positions as may be agreed to by Executive and the Board of Directors of the Company
(the “Board”). Executive shall in his capacity as an employee and officer of the Company be responsible to and obey the reasonable and lawful directives of the Board consistent with this Agreement and shall report directly to
the Board. 
 (b) Executive shall devote his full time and attention to such duties, except for sick leave, reasonable vacations,
and excused leaves of absences as more particularly provided herein, provided that so long as this does not interfere to any substantial extent with Executive’s duties, Executive may manage his personal investments, be involved in charitable
and professional activities and, with the consent of the Board, serve on for profit boards and advisory committees, provided that nothing in this Section 2(b) shall override Executive’s obligations in Section 7 hereof. 

(c) Executive currently resides in the New York City area, and the Company agrees that he shall not be required to relocate his residence
from that area without his prior 

  
 - 1 -









 
written consent (which may be withheld in his sole discretion), or from any other area to which he may voluntarily move with the Company’s prior written consent, during the Term of the
Executive’s employment. 
 (d) Executive is a member of the Board, and the Company intends that he remain on the Board while
serving as Chief Financial Officer but this is not intended to represent a contractual undertaking that he remain on the Board and he further acknowledges the provisions of Section 6(b) below with respect to his post-employment service.

 3. Compensation. 
 (a) Base Salary. The Company shall pay to Executive while employed after the Effective Date a rate of not less than Three Hundred Thousand Dollars ($300,000) per year, payable at least monthly in
accordance with the Company’s normal payroll practices, and agrees that such salary shall be reviewed at least annually, beginning with a review on or around the first anniversary of the Effective Date. On the first annual anniversary of the
date hereof (and each subsequent annual anniversary thereafter during which this Agreement is in effect), Executive’s salary shall be increased by an increment of the then generally accepted cost-of-living percentage increase and any other
discretionary annual increases as determined by the Compensation Committee of the Board of Directors. (Executive’s annual salary, as set forth above or as it may be increased from time to time as set forth herein, shall be referred to
hereinafter as “Base Salary.”) 
 (b) Signing Bonus, Performance Bonus and Equity Compensation.
The Company shall pay Executive a signing bonus of $25,000 in the first payroll beginning after he executes this Agreement. Executive shall be eligible to receive an annual discretionary bonus (“Bonus”), targeted at 40% of
Executive’s Base Salary, the achievement of such Bonus to be based on the satisfaction of objective criteria and performance standards as established in advance and agreed to by Executive and the Compensation Committee of the Board with respect
to each fiscal year ending while Executive is employed under this Agreement, other than the 2010 fiscal year. The Compensation Committee has agreed to award Executive an option for 100,000 shares of the common stock of the Company (the
“Option”), contingent on Executive’s executing this Agreement, with the date of grant as soon as practicable after the Effective Date. The Option will be subject to the terms and conditions of the Stock Incentive Plan
and the provisions of an option agreement reflecting the grant. The Option will vest and become exercisable as to 25% of the covered shares on the first anniversary of the Effective Date and as to an additional 2.08333% on the same day in each
subsequent month, assuming continued employment. 
 (c) Effect of Acquisition Event. Vesting of all stock options will
fully accelerate immediately prior to (and subject to) or in connection with the closing of an “Acquisition Event” as defined in the Trimeris, Inc. 2007 Stock Incentive Plan (the “Stock Incentive
Plan”); in addition any stock options that remain outstanding after the closing of the Acquisition Event shall remain exercisable until the earlier to occur of the fifth 

  
 - 2 -









 
anniversary of the Acquisition Event or the original ten year term of the options. If Executive’s employment ends for any reason while any portion of the stock options are unvested (and do
not vest under the preceding sentence or Section 6(d)(iii)), the unvested portion will be immediately forfeited, unless the Compensation Committee provides otherwise. 
 4. Benefits During the Term of Employment. 
 (a) Executive shall be eligible
to participate in any life, health and long-term disability insurance programs, pension and retirement programs, stock option and other incentive compensation programs, and other fringe benefit programs made available to senior executive employees
of the Company from time to time (subject, in the case of life, health and long-term disability insurance programs, to his qualifying under the terms of the insurance coverage), at a level commensurate with his position, and Executive shall be
entitled to receive such other fringe benefits as may be granted to him from time to time by the Company’s Board of Directors. 
 (b) Executive shall be allowed four weeks of vacation with pay and leaves of absence with pay on the same basis as other senior executive employees of the Company. 

(c) The Company shall reimburse Executive for reasonable business expenses incurred in performing Executive’s duties and promoting
the business of the Company, including, but not limited to, reasonable entertainment expenses, travel and lodging expenses, following presentation of documentation in accordance with the Company’s business expense reimbursement policies. The
foregoing shall include all expenses related to travel by Executive between New York and North Carolina and any lodging expenses incurred by Executive in North Carolina in connection with the performance of his services under this Agreement.
Executive shall use reasonable judgment in purchasing upgradeable coach class tickets for all cross-country flights and upgradeable business class tickets for all international flights. Payments with respect to reimbursement of business expenses
will be made in the ordinary course and, in any case, on or before the last day of the calendar year following the calendar year in which the relevant expense is incurred. The amount of expenses eligible for reimbursement, or in-kind benefits
provided, during a calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year, and the right to reimbursement or in-kind benefits is not subject to liquidation or exchange for
another benefit. 

  
 - 3 -









 5. Term; Termination of Employment. 

As used herein, the phrase “Term of Employment” begins with the Effective Date and shall continue indefinitely.
Notwithstanding the foregoing, the Term of Employment shall end on the first to occur of the following: 
 (a) Termination by
the Company. 
 (i) Notwithstanding anything to the contrary in this Agreement, whether
express or implied, the Company may, at any time, terminate Executive’s employment for any or no reason by giving Executive written notice of the effective date of termination. Nothing in this section prevents the Company from removing
Executive from service during the period, if any, between notice and effectiveness. Executive’s employment shall automatically terminate on the 60th day following a Change in Business Direction and such termination shall be treated as without Cause (unless he has
previously received notice of termination for Cause), unless Executive and the Company agree to a later termination that satisfies, if necessary, the requirements of Treas. Reg. § 1.409A-3(i)(5)((iv)(B) or another exception to payment of any
compensation that is treated as subject to Section 409A of the Internal Revenue Code of 1986 (“Section 409A” of the “Code”). 

(ii) “Cause” shall mean: 

(I) fraud, misappropriation, embezzlement, or other act of material misconduct against the Company or any of its
affiliates; 
 (II) substantial and willful failure to perform specific and lawful written directives of the
Board; 
 (III) willful and knowing violation of any rules or regulations of any governmental or regulatory body
that is materially injurious to the financial condition of the Company; 
 (IV) conviction of or plea of guilty
or nolo contendere to a felony; or 
 (V) a material breach of the terms and conditions of this Agreement.

 provided, however, that with regard to subclauses (II) and (V) above, Executive may not be terminated for
Cause unless and until the Board has given him reasonable written notice of their intended actions and specifically describing the alleged events, activities or omissions giving rise thereto and with respect to those events, activities or omissions
for which a cure is possible, 30 days to cure such breach; and provided further, however, that for purposes of determining whether any such Cause is present, no act or failure to act by Executive shall be considered “willful”
if done or omitted to be done by Executive in good faith and in the reasonable belief that such act or omission was in the best interest of the Company and/or required by applicable law. 

(iii) “Change in Business Direction” shall mean any transaction (i.e., a merger, stock or asset
purchase, or sale of stock or assets) (i) by which the Company acquires the assets or stock of, is itself or its assets are acquired by, or merges with an entity that operates a business other than a collaboration with F. Hoffmann-La Roche Ltd
and Hoffmann-La Roche Inc. relating to the sale of FUZEON and the management of cash flows therefrom (the “Current Business”) or (ii) that results in the combined enterprise’s operation of a business other than the
Current Business, provided that a transaction will not constitute a Change in Business Direction unless, for purposes of 

  
 - 4 -









 
either clause (i) or clause (ii) in this sentence, the Company’s contribution to or payment for or in connection with the transaction is at least equal to the least of (x) $10
million, (y) 20% of fair market value of the Company’s then total net assets or (z) 20% of the market value of the then total outstanding common stock of the Company and provided further that neither the liquidation of the
Company’s assets to cash without reinvestment in new lines of business (other than passive investments) nor the distribution or dividend of its assets to its shareholders, whether as an interim matter or in complete liquidation of the Company,
would constitute a Change in Business Direction. The parties intend and expect the Change in Business Direction contingency to be a substantial risk of forfeiture for purposes of Treas. Reg. § 1.409A-1(d). 

(iv) “Disability” shall mean that as a result of Executive’s incapacity due to physical or
mental illness (as determined in good faith by a physician acceptable to the Company and Executive), Executive shall have been absent from the full-time performance of his duties with the Company for 120 consecutive days during any 12 month
period or if a physician acceptable to the Company and Executive advises the Company that it is likely that Executive will be unable to return to the full-time performance of his duties for 120 consecutive days during the succeeding 12 month
period. 
 (b) Termination by Executive. 

(i) Notwithstanding anything to the contrary in this Agreement, whether express or implied, the Executive may terminate
his employment with the Company at any time with or without Good Reason upon at least 30 days’ advance written notice of his intention to terminate his employment hereunder. 

(ii) “Good Reason” shall mean the occurrence of any of the following events, provided that the
Executive gives written notice of his intent to resign pursuant to such event within 90 days following such occurrence and provided that such event is not fully corrected within 30 days following written notification by Executive to the Company that
he intends to terminate his employment hereunder for one of the reasons set forth below: 
 (I) a material breach
by the Company of any provision of the Employment Agreement including, but not limited to, the assignment to Executive of any duties inconsistent with Executive’s position as Chief Financial Officer in the Company or the Company’s removal
of Executive as Chief Financial Officer; 
 (II) a material adverse alteration in the nature or status of
Executive’s responsibilities; or 
 (III) a material reduction in Executive’s then current Base Salary.

 Executive must actually terminate his employment within 30 days following the Company’s failure to cure the applicable
event to be treated as resigning for Good Reason. 

  
 - 5 -









 6. Salary and Benefits Upon Termination. 

(a) Accrued Amounts and Rights. 
 (i) In the event of termination of employment, Executive shall receive all regular Base Salary due up to the date of termination, any accrued but unused vacation (if and to the extent consistent with the
Company’s policies), any incurred but unreimbursed business expenses, and if it has not previously been paid to Executive, Executive shall be paid any unpaid Bonus due to Executive for any fiscal year ending prior to the effective date of such
termination, any rights under any benefit or equity plan, program or practice and his rights to indemnification and directors and officers liability insurance (the “Accrued Amounts and Rights”). For purposes of this
Section 6, “Base Salary” shall mean Executive’s regular rate of pay at the time of termination and shall not include bonus or incentive plans, overtime pay, relocation allowances or the value of any other benefits
for which Executive may be eligible and shall be before any deferrals. 
 (ii) Except as provided in
Section 3(c) or Section 6(d)(iii), any of Executive’s unvested stock options shall immediately expire and be forfeited on the date Executive’s employment ends, and all of his then vested stock options shall be exercisable in
accordance with the terms of the applicable grant agreements. Nothing in this Agreement shall be construed as giving Executive any additional rights relating to options or other equity compensation other than those described in this Agreement or the
respective grants. Executive’s right to severance benefits, if any, shall be governed by the terms of this Agreement. 
 (iii) Section 6 provides the sole and exclusive agreement concerning severance benefits for Executive in the event of a termination and replaces any and all prior plans, policies and practices
relating to severance pay that may exist now or may have existed in the past. 
 (b) Further Effect of Termination on Board
and Officer Positions. If Executive’s employment ends for any reason, Executive agrees that he will cease immediately to hold any and all officer or director positions he then has with the Company or any subsidiary, absent a contrary
direction from the Board (which may include either a request to continue such service or a direction to cease serving upon notice without regard to whether his employment has ended), except to the extent that Executive reasonably and in good faith
determines that ceasing to serve as a director would breach his fiduciary duties to the Company. Executive hereby irrevocably appoints the Company to be his attorney-in-fact to execute any documents and do anything in his name to effect his ceasing
to serve as a director and officer of the Company and any subsidiary, should he fail to resign following a request from the Company to do so. A written notification signed by a director or duly authorized officer of the Company that any instrument,
document or act falls within the authority conferred by this clause will be conclusive evidence that it does so. 

  
 - 6 -









 (c) Responsibility for Benefits. The Company will pay the entire cost of all benefits
provided under Sections 6(a) and 6(d) of this Agreement, solely from its general assets. The benefits made available by those provisions are “unfunded.” 
 (d) Payment of Benefits 
 (i) In the
event Executive’s employment is terminated by the Company other than for Cause (and excluding Disability and death) or the Executive terminates employment for Good Reason, Executive shall receive the following severance benefits upon his
satisfaction of the condition in subsection (e) hereof and subject to subsection (g) hereof: an amount equal to 12 months of the Executive’s Base Salary, paid in installments in accordance with the regular payroll timing, with payment
to begin on the payroll date next following or coinciding with the date 60 days after employment ends. Notwithstanding the foregoing, to the extent permissible under Section 409A of the Code, the payments due after such 60 day period will be
accelerated and be paid on such 60th day if and to the
extent those amounts are otherwise exempt from treatment as deferred compensation under Section 409A and the Board determines that acceleration is appropriate. 

(ii) Reserved. 
 (iii) In the event Executive’s employment is terminated (whether by the Company or by Executive) as described in subsection (d)(i) above within 60 days (with any extensions necessary to complete the
notice and cure periods under 5(b)(ii)) following a Change in Business Direction, Executive will receive a bonus equal to (i) the target bonus plus (ii) an additional pro-rata portion of the target bonus, with the proration based on the
portion of the fiscal year that has elapsed by the date of the closing (together, the “Change in Business Direction Bonus”), assuming he remains employed as of the closing of the Change in Business Direction. Payment of the
Change in Business Direction Bonus will be made in a single lump sum paid at the same time as the first or only payment under Section 6(d)(i). In addition, upon a termination or resignation covered by this clause (iii), the option treatment
specified in Section 3(c) will also apply even if no Acquisition Event has occurred. 
 (iv) In the event
Executive’s employment is terminated (whether by the Company or by Executive) as described in subsection (d)(i) above within 60 days (with any extensions necessary to complete the notice and cure periods under 5(b)(ii)) following a complete
liquidation of the Company that does not otherwise constitute a Change in Business Direction, Executive will receive a bonus equal to the target bonus, multiplied by a Time Factor. The “Time Factor” will be zero until
January 17, 2011, one-third from January 17 until March 17, 2011, 50% from March 17 until May 17, 2011, and 100% on and after May 17, 2011. Payment under this clause (iv) will be made in a single lump sum paid at
the same time as the first or only payment under Section 6(d)(i). 
 (e) Conditions to Receipt of Benefits. Upon the
occurrence of one or more events described in Section 6(d) above, Executive will be eligible for payments and benefits under Section 6(d) (other than option acceleration) only if Executive executes and


  
 - 7 -









 
delivers to the Company a Settlement Agreement and Release of the Company in a form prepared by the Company, which will include a general release of known and unknown claims, a return of Company
property, nondisparagement and a requirement to cooperate regarding any future litigation. This release must become irrevocable no later than 60 days following the date employment ends. 

(f) Termination Events Not Covered. Except as specifically set forth in this Agreement, the Company shall not pay Executive
severance benefits under this Agreement if: 
 (i) Executive dies during the term of his employment; 

(ii) Executive’s employment is terminated for Cause or Disability, as defined herein; 

(iii) Executive terminates his employment with Company for a reason other than Good Reason as defined herein; or

 (iv) Executive revokes his agreement to release the Company from any and all claims related to his employment
pursuant to the Settlement Agreement and Release executed in satisfaction of Section 6(e) hereof. 
 (g) Tax Treatment;
Section 409A. Executive’s severance benefits shall be subject to mandatory withholding, including federal, state and local income taxes, as well as FICA and withholding for applicable insurance premiums. If and to the extent any
portion of any payment, compensation or other benefit provided to Executive in connection with his “separation from service” as determined under Section 409A is determined to constitute “nonqualified deferred compensation”
within the meaning of Section 409A and the Employee is a specified employee as defined in Section 409A(a)(2)(B)(i), as determined by the Company in accordance with its procedures, by which determination Executive hereby agrees that he is
bound, such portion of the payment, compensation or other benefit shall not be paid before the day that is six months plus one day after the date of separation from service (the “New Payment Date”), except as
Section 409A may then permit. The aggregate of any payments that otherwise would have been paid to Executive during the period between the date of separation from service and the New Payment Date shall be paid to Executive in a lump sum on such
New Payment Date, and any remaining payments will be paid on their original schedule. For purposes of this Agreement, each amount to be paid or benefit to be provided shall be construed as a separate identified payment for purposes of
Section 409A, and any payments described in Section 6 that are due within the “short term deferral period” as defined in Section 409A shall not be treated as deferred compensation unless applicable law requires otherwise.
Neither the Company nor Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A. This Agreement is intended to comply with the
provisions of Section 409A and the Agreement shall, to the extent practicable, be construed in accordance therewith. Terms defined in the Agreement shall have the meanings given such terms under Section 409A if and to the extent required
to comply with Section 409A. Notwithstanding the foregoing, to the extent that the Agreement or any payment 

  
 - 8 -









 
or benefit hereunder shall be deemed not to comply with Section 409A, then neither the Company, the Board nor its or their designees or agents shall be liable to Executive or any other
person for any actions, decisions or determinations made in good faith. 
 (h) Parachute Treatment. The Company will make
the payments under or referenced by this Agreement without regard to whether the deductibility of such payments (or any other payments or benefits) would be limited or precluded by Section 280G of the Code and without regard to whether such
payments would subject Executive to the federal excise tax levied on certain “excess parachute payments” under Section 4999 of the Code; provided, however, that if the Total After-Tax Payments (as defined below) would be
increased by the reduction or elimination of any payment and/or other benefit (including any vesting of stock options) under this Agreement, then the amounts payable under this Agreement will be reduced or eliminated as follows: (i) first, by
reducing or eliminating any cash payments or other benefits (other than the vesting of the stock options) and (ii) second, by reducing or eliminating the vesting of the stock options that occurs as a result of an event covered by
Section 280G of the Code, to the extent necessary to maximize the Total After-Tax Payments. The Company’s independent, certified public accounting firm will determine whether and to what extent payments or vesting under this Agreement are
required to be reduced in accordance with the preceding sentence. If there is an underpayment or overpayment under this Agreement (as determined after the application of this paragraph), the amount of such underpayment or overpayment will be
immediately paid to Executive or refunded by Executive, as the case may be, with interest at the applicable federal rate provided for in Section 7872(f)(2) of the Code. For purposes of this Agreement, “Total After-Tax
Payments” means the total of all “parachute payments” (as that term is defined in Section 280G(b)(2) of the Code) made to or for the benefit of Executive (whether made under the Agreement or otherwise), after reduction
for all applicable federal taxes (including, without limitation, the tax described in Section 4999 of the Code). 
 7. Confidential
Information, Non-Solicitation and Non-Competition. 
 (a) Executive acknowledges and agrees that: 

(i) As a result of his employment with the Company, Executive will become knowledgeable of and familiar with the Company’s
Confidential Information (as defined below), including know-how related to the Company’s services, plus the special requirements or preferences of the Company’s research, development, marketing, licensing agreements or arrangements and
investor relations, so that he would have a competitive advantage against the Company following termination of his employment with the Company absent the protection afforded by the restrictive covenants in this Section 7 (the
“Restrictive Covenants”); 
 (ii) The time, territory and scope of the Restrictive Covenants are
reasonable and necessary for protection of the Company’s legitimate business interests; 
 (iii) Executive has received
sufficient and valuable consideration in exchange for his agreement to the Restrictive Covenants, including but not limited to his salary and benefits under this Agreement, the possibility of severance benefits pursuant to Section 6 hereof and
any other consideration provided to him under this Agreement; 

  
 - 9 -









 (iv) Executive agrees that the non-compete covenant of Section 7(c) will not impose
undue hardship on Executive or prevent Executive from being able to earn an adequate living following termination of this Agreement; 
 (v) While the Company employs Executive, he agrees that he will not, without the Board’s prior written consent, directly or indirectly, provide services to any other person or organization. (This
prohibition excludes any work performed at the Company’s direction.) Executive represents to the Company that he is not subject to any agreement, commitment, or policy of any third party that would prevent him from entering into or performing
his duties under this Agreement, and he agrees that he will not enter into any agreement or commitment that would prevent or hinder his performance of duties and obligations under this Agreement, provided that this Section 7(a)(v) shall not
limit Executive’s accepting future employment while employed hereunder, provided he promptly notifies the Company of such acceptance; 
 (vi) The parties agree that the Company may request an arbitrator or court to take into account as part of an equitable or other remedy an extension of the time period of protection provided by the
Restrictive Covenants for any period of time during which Executive is in violation of such covenants and any period of time required for litigation to enforce such covenants and Executive may oppose any such request; and 

(vii) Executive has read and reviewed the Restrictive Covenants before agreeing to the terms of this Agreement. 

(b) During the Term of Employment and at all times thereafter, Executive shall not, except as he deems necessary or desirable in good
faith discretion to perform his duties hereunder or as required by applicable law, disclose to others or use, whether directly or indirectly, any Confidential Information regarding the Company. “Confidential Information”
shall mean information about the Company, its subsidiaries and affiliates, and their respective clients and customers that is not available to the general public or generally known in the industry and that was learned by Executive in the course of
his employment by the Company, including (without limitation) (i) any proprietary knowledge, trade secrets, ideas, processes, formulas, cell lines, sequences, developments, designs, assays and techniques, data, formulae, and client and customer
lists and all papers, resumes, records (including computer records), (ii) information regarding plans for research, development, new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices
and costs, suppliers and customers (iii) information regarding the skills and compensation of other employees of Company and (iv) the documents containing such Confidential Information. Executive’s rolodex and similar address books
shall not be deemed Confidential Information if and to the extent they contain only the names and contact information he has personally used while employed (or acquired prior to employment 

  
 - 10 -









 
hereunder) and no other information that would otherwise be Confidential Information. Executive acknowledges that such Confidential Information is specialized, unique in nature and of great value
to the Company, and that such information gives the Company a competitive advantage. Upon the termination of employment for any reason whatsoever, Executive shall promptly deliver to the Company all documents, slides, computer tapes and disks (and
all copies thereof) containing any Confidential Information. 
 (c) During the Term of Employment and for the one year
thereafter, Executive shall not, directly or indirectly in any manner or capacity (e.g., as an advisor, principal, agent, partner, officer, director, shareholder, employee, member of any association or otherwise) engage in, work for, consult,
provide advice or assistance or otherwise participate in any activity with respect to a Competing Business, as defined below and except as provided below, provided, however, that the “beneficial ownership” by Executive,
either individually or as a member of a “group,” as such terms are used in Rule 13d of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) of
not more than three percent of the voting stock of any publicly held corporation shall not be a violation of this Agreement. Executive agrees that the market area for the Company is worldwide and that, by the nature of the business, it operates
globally. Executive also expressly agrees that the Company will or would suffer irreparable injury if Executive were to compete with the Company or any subsidiary or affiliate of the Company in violation of this Agreement. 

“Competing Business” is defined as the business of the discovery, development, testing, manufacturing, and/or
marketing therapeutic components for the treatment of human viral diseases based on a viral fusion protein target and any other business in which the Company may engage or propose to engage during the term of this Agreement, with the proposed
businesses being documented by Board minutes or written Company business plans during the Term of Employment. 
 (d) During the
Term of Employment and for one year thereafter, Executive shall not, directly or indirectly, influence or attempt to influence customers or suppliers of the Company or any of its subsidiaries or affiliates, to divert their business to any Competing
Business for which subsection (c) would prevent his employment. 
 (e) Executive recognizes that he will possess
confidential information about other employees of the Company relating to their education, experience, skills, abilities, compensation and benefits, and interpersonal relationships with customers of the Company. Executive recognizes that the
information he will possess about these other employees is not generally known, is of substantial value to the Company in developing its business and in securing and retaining customers, and will be acquired by him because of his business position
with the Company. Executive agrees that, during the Term of Employment (except in the good faith performance of his duties), and for a period of one year thereafter, he will not, directly or indirectly, solicit or recruit any employee of the Company
for the purpose of being employed by him or by any competitor of the Company on whose behalf he is acting as an agent, representative or employee. 

  
 - 11 -









 (f) Executive agrees and understands that Company has received, and in the future will
receive, from third parties confidential or proprietary information (“Third Party Information”) subject to a duty on Company’s part to maintain the confidentiality of such information and to use it only for certain
limited purposes. During the term of Executive’s employment and thereafter, Executive will hold Third Party Information in the strictest of confidence and will not disclose (to anyone other than Company personnel who Executive in good faith
determines need to know such information in connection with their work for Company), or use, except in connection with his duties for Company, Third Party Information unless required by legal process. 

(g) Inventions 
 (i) Assignment. Executive hereby assigns to Company all his right, title and interest in and to any and all Inventions (and all patent rights, copyright, trade secret rights and all other rights
throughout the world in connection therewith, whether or not patentable or registerable under copyright, trademark or similar statutes), together with all goodwill associated therewith, (all of the foregoing being hereinafter referred to
collectively as “Proprietary Rights”), made, conceived, reduced to practice or learned by Executive, either alone or jointly with others, during his period of employment (and prior consulting arrangement) with Company.
Inventions assigned under this Section 7 are hereinafter referred to as “Company Inventions”. Executive agrees to reasonably assist Company in every reasonably necessary way (but at Company’s expense) to obtain or
enforce any patents, copyrights or any proprietary rights relating to Company Inventions and to execute all documents and applications necessary to vest in Company’s full legal title to such Company Inventions, and Executive agrees to continue
this assistance after the termination of his employment with Company. Furthermore, Executive hereby designates and appoints Company and its officers and agents as his agents and attorneys-in-fact to execute and file any certificates, applications or
documents and to do all other lawful acts reasonably necessary in the opinion of Company to protect Company’s rights in Company Inventions. Executive expressly acknowledges that the foregoing power of attorney is coupled with an interest and is
therefore irrevocable and will survive Executive’s termination of employment, death or incompetency. 
 (ii)
Government. Executive also will assign to or as directed by Company all his right, title and interest in and to any and all Inventions, full title to which may be required to be in the United States by a contract between Company and the
United States or any of its agencies. 
 (iii) Independent Inventions. Notwithstanding anything in this Agreement to the
contrary, Executive’s obligation to assign or offer to assign Executive’s rights in an Invention to Company will not extend or apply to an Invention that Executive has developed entirely on Executive’s own time without using
Company’s equipment, supplies, facilities or trade secret information unless such Invention: (a) relates to Company’s business or actual demonstrably anticipated research or development or (b) results from any work performed by
Executive for Company. Executive will bear the burden of proof in establishing that the Invention qualifies for exclusion under this Section 7(g)(iii). 

  
 - 12 -









 (iv) Assignment of Company Inventions. Executive will reasonably assist Company in
every proper way to obtain and from time to time enforce United States and foreign Proprietary Rights related to Company Inventions in any and all countries. Executive’s obligation to reasonably assist Company with respect to Proprietary Rights
relating to such Company Inventions will continue beyond the termination of Executive’s employment, but Company will compensate Executive at a reasonable rate after Executive’s termination for the time actually spent by executive at
Company’s request on such assistance. 
 Executive hereby waives and quitclaims to Company all claims, of any nature
whatsoever, which Executive may or may hereafter have for infringement, including past infringements, of any Proprietary Rights assigned hereunder to Company. 
 (v) Obligation to Keep Company Informed. During the period of Executive’s employment, Executive will promptly disclose to Company fully and in writing, and will hold in trust for the sole
right and benefit of Company, any and all Inventions. In addition, after termination of Executive’s employment, Executive will disclose any filing of any patent applications by him or on his behalf within a year after termination of such
employment. 
 (vi) Prior Inventions. Inventions, if any, patented or unpatented, which Executive made prior to
Executive’s commencement of employment with Company are excluded from the scope of this Agreement. To preclude any possible uncertainty, Executive has set forth on the attached Exhibit A, a complete list of all Inventions that Executive
has, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of or during Executive’s employment with Company, that Executive
considers to be Executive’s property or the property of the third parties, and Executive wishes to have excluded from the scope of this Agreement. If disclosure of any such Invention on Exhibit A would cause Executive to violate any
prior confidentiality agreement with another party, Executive understands that he is not to list such Inventions in Exhibit A but that Executive is to inform Company in writing that all such Inventions have not been listed for that reason.

 If it is determined by a court of competent jurisdiction in any state that any restriction in this Section 7 is excessive
in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the
law of that state. 
 8. Return of Company Documents. In the event Executive leaves the employment of Company for whatever reason,
Executive agrees to deliver to Company any and all laboratory notebooks, drawings, notes, memoranda, specifications, devices, software, databases, formulas, 

  
 - 13 -









 
molecules, cells and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Confidential Information of
Company. Executive further agrees that any property situated on Company’s premises and owned by Company including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at any time,
with or without notice, for the purpose of protecting Company’s rights and interests in its intellectual property. 
 9. Taxes. All
payments to be made to Executive under this Agreement will be subject to any applicable withholding of federal, state and local income and employment taxes. 
 10. Miscellaneous. This Agreement shall also be subject to the following miscellaneous considerations: 
 (a) Executive and the Company each represent and warrant to the other that he or it has the authorization, power and right to deliver, execute, and fully perform his or its obligations under this
Agreement in accordance with its terms. 
 (b) This Agreement (including the attached Exhibits) contains a complete
statement of all the arrangements between the parties with respect to Executive’s employment by the Company. This Agreement supersedes all prior and existing negotiations and agreements between the parties concerning Executive’s employment
and is specifically intended to supersede any less employee favorable provisions in stock option agreements. This Agreement can only be changed or modified pursuant to a written instrument duly executed by each of the parties hereto. 

(c) If any provision of this Agreement or any portion thereof is declared invalid, illegal, or incapable of being enforced by any court of
competent jurisdiction, the remainder of such provisions and all of the remaining provisions of this Agreement shall continue in full force and effect. 
 (d) This Agreement shall be governed by and construed in accordance with the internal, domestic laws of the State of North Carolina. 

(e) The Company may assign this Agreement to any parent of the Company that owns all of the stock of the Company. The Company may only
assign this Agreement to a successor (whether by merger, consolidation, purchase or otherwise) of all or substantially all of the stock, assets or business of the Company and this Agreement shall be binding upon and inure to the benefit of such
successors and assigns, provided that such successor promptly delivers to Executive a written assumption of the obligations hereunder. Except as expressly provided herein, Executive may not sell, transfer, assign, or pledge any of his rights or
interests pursuant to this Agreement, provided that any amounts due hereunder shall, upon Executive’s death, be paid to his estate unless Executive has designated a beneficiary therefor in accordance with any applicable plan. 

(f) Any rights of Executive hereunder shall be in addition to any rights Executive may otherwise have under benefit plans of the Company
to which he is a party or in which he is a participant, including, but not limited to, any Company-sponsored employee benefit plans. Provisions of this Agreement shall not in any way abrogate Executive’s rights under such other plans.


  
 - 14 -









 (g) For the purpose of this Agreement, notices and all other communications provided for in
this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally or by overnight service or delivered or mailed by United States certified or registered mail, return receipt requested, postage prepaid,
addressed to the Company at its executive office or the Executive at the address on the records of the Company; provided that all notices to the Company shall be directed to the attention of the Chairman of the Board of Directors with a copy to the
Secretary of the Company, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

(h) Section headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this
Agreement for any other purpose. 
 (i) Failure to insist upon strict compliance with any of the terms, covenants, or conditions
hereof shall not be deemed a waiver of such term, covenant, or condition, nor shall any waiver or relinquishment of, or failure to insist upon strict compliance with, any right or power hereunder at any one or more times be deemed a waiver or
relinquishment of such right or power at any other time or times. 
 (j) This Agreement may be executed in several counterparts,
each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 
 (k)
Executive acknowledges that no representation, promise or inducement has been made other than as set forth in the Agreement, and that he does not enter into this Agreement in reliance upon any representation, promise or inducement not set forth
herein. The Agreement supersedes all prior negotiations and understandings of any kind with respect to the subject matter and contains all of the terms and provisions of the agreement between Executive and the Company with respect to the subject
matter hereof. Any representation, promise or condition, whether written or oral, not specifically incorporated herein, shall be of no binding effect. 
 11. Legal and Equitable Remedies. Because the Executive’s services are personal and unique, and because the Executive will have access to and become acquainted with Proprietary Rights, Company
Inventions and Confidential Information of Company, Company will have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other equitable relief in any court of competent jurisdiction, without
prejudice to any other rights and remedies that Company may have for a breach of this Agreement. 
 12. Survival of Provisions. The
executory provisions of this Agreement will survive the termination of this Agreement or the assignment of this Agreement by Company to any successor in interest or other assignee. 

  
 - 15 -









 13. Resolution of Disputes. Except as otherwise specifically provided in Section 11 above, any
dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration administered by the American Arbitration Association and conducted before one arbitrator in New York City, New York, all in
accordance with its Commercial Arbitration rules then in effect. The Company and Executive hereby agree that the arbitrator will not have the authority to award punitive damages, damages for emotional distress or any other damages that are not
contractual in nature. Judgment shall be final and binding upon the parties and judgment may be entered on the arbitrator’s award in any court having jurisdiction; provided, however, that the Company shall be entitled to seek a
restraining order or injunction in any court of competent jurisdiction to prevent any violation or the continuation thereof, of the provisions of Section 7 of this Agreement, and Executive consents that such restraining order or injunction may
be granted without the necessity of the Company’s posting any bond except to the extent otherwise required by applicable law. 
 14.
Legal Fees. In the event of any dispute in connection with this Agreement, to the extent permitted by applicable state law, if the arbitrator or judge, as the case may be, determines that the Executive has prevailed in such dispute, the
Executive shall be awarded his reasonable legal fees, disbursements and costs; provided that if the arbitrator or judge determines that the Company has prevailed and that the dispute by the Executive was frivolous or brought in bad faith, the
Company shall instead be awarded its reasonable legal fees, disbursements and costs. 
 15. Indemnification. The Executive shall be
indemnified to the fullest extent permitted by law with regard to actions or inactions taken as an officer or director of the Company or any affiliate or as a fiduciary of any benefit plan. The Executive shall be covered by directors and officers
liability insurance with regard to the foregoing to the highest extent of any other officer or director both during his service to the Company and thereafter while any liability may exist. 

Signatures on Page Following 

  
 - 16 -









 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first
above written. 
  

									
	EXECUTIVE	 		 	TRIMERIS, INC.
					
	By:	 	 /s/ James R. Thomas
	 		 	By:	 	 /s/ Martin A. Mattingly

	Name:	 	James R. Thomas	 		 	Name:	 	Martin A. Mattingly


  
 - 17 -









 EXHIBIT A 
 TO 
 EXECUTIVE EMPLOYMENT AGREEMENT 

The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by Company that have been made or
conceived or first reduced to practice by me alone or jointly with others prior to my employment by Company and therefore should be excluded from the coverage of this Agreement: 
              Additional sheets attached. 
              No pertinent inventions or improvements. 
              Due to confidentiality agreements with one or more prior employers, I cannot disclose certain inventions that would
otherwise be included on the above-described list. 
 I propose to bring to my employment the following devices, materials and documents of a
former employer or other person to whom I have an obligation of confidentiality and that are not generally available to the public. These materials and documents may be used in my employment pursuant to the express written authorization of my former
employer or such other person (a copy of which is attached hereto). If no such authorization is in place, I will consult with Company management to determine what steps should be taken to protect the interests of all parties concerned. 

             Additional sheets attached. 

             No material. 

 

	
	EXECUTIVE:
	
	 /s/

	James R. Thomas


			
		
	Date:	 	  



  
 - 18 -









 Attachment to Exhibit A 

(Prior Inventions) 
 None 

  
 - 19 -